Colleen C Nelson (Colleen Nelson)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 9

Top Topics

Radical Prostatectomy

Lymph Node Metastasis

Top Venues

Cell death & disease

Science advances

Current oncology (Toronto, Ont.)

G3 (Bethesda, Md.)

This page only lists publications with an associated author ORCID identifier.

Publications

Charles L Bidgood, Lisa K Philp, Anja Rockstroh, Melanie Lehman, Colleen C Nelson, Martin C Sadowski, Jennifer H Gunter
Targeting valine catabolism to inhibit metabolic reprogramming in prostate cancer. Cell death & disease 15 (7) (2024)
Charles L Bidgood, Lisa K Philp, Anja Rockstroh, Melanie Lehman, Colleen C Nelson, Martin C Sadowski, Jennifer H Gunter
Targeting valine catabolism to inhibit metabolic reprogramming in prostate cancer. Cell death & disease 15 (7) (2024)
Charles L Bidgood, Lisa K Philp, Anja Rockstroh, Melanie Lehman, Colleen C Nelson, Martin C Sadowski, Jennifer H Gunter
Targeting valine catabolism to inhibit metabolic reprogramming in prostate cancer. Cell death & disease 15 (7) (2024)
Charles L Bidgood, Lisa K Philp, Anja Rockstroh, Melanie Lehman, Colleen C Nelson, Martin C Sadowski, Jennifer H Gunter
Targeting valine catabolism to inhibit metabolic reprogramming in prostate cancer. Cell death & disease 15 (7) (2024)
Patrick B Thomas, Saeid Alinezhad, Andre Joshi, Katrina Sweeney, Brian W-C Tse, Gregor Tevz, Stephen McPherson, Colleen C Nelson, Elizabeth D Williams, Ian Vela
Introduction of Androgen Receptor Targeting shRNA Inhibits Tumor Growth in Patient-Derived Prostate Cancer Xenografts. Current oncology (Toronto, Ont.) 30 (11) (2023)
Smriti Chawla, Anja Rockstroh, Melanie Lehman, Ellca Ratther, Atishay Jain, Anuneet Anand, Apoorva Gupta, Namrata Bhattacharya, Sarita Poonia, Priyadarshini Rai, Nirjhar Das, Angshul Majumdar, null Jayadeva, Gaurav Ahuja, Brett G Hollier, Colleen C Nelson, Debarka Sengupta
Gene expression based inference of cancer drug sensitivity. Nature communications 13 (1) (2022)
Nathalie Bock, Thomas Kryza, Ali Shokoohmand, Joan Röhl, Akhilandeshwari Ravichandran, Marie-Luise Wille, Colleen C Nelson, Dietmar Werner Hutmacher, Judith A Clements
In vitro engineering of a bone metastases model allows for study of the effects of antiandrogen therapies in advanced prostate cancer. Science advances 7 (27) (2021)
Claire Levrier, Anja Rockstroh, Brian G Gabrielli, Maria Kavallaris, Melanie L Lehman, Rohan A Davis, Martin C Sadowski, Colleen C Nelson
Discovery of thalicthuberine as a novel antimitotic agent from nature that disrupts microtubule dynamics and induces apoptosis in prostate cancer cells. Cell cycle (Georgetown, Tex.) 17 (5) (2019)
Inge Seim, Penny L Jeffery, Patrick B Thomas, Colleen C Nelson, Lisa K Chopin
Whole-Genome Sequence of the Metastatic PC3 and LNCaP Human Prostate Cancer Cell Lines. G3 (Bethesda, Md.) 7 (6) (2017)
Andreas Doll, Jeremy Clark, Colleen C Nelson
Biomarker and translational prostate cancer research. BioMed research international 2015 (2015)